This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q79.1 (other congenital malformations of diaphragm) | Special Copayment Reduction: V155 |
| B. Synonyms | Absence of diaphragm, eventration of diaphragm, other congenital malformations of diaphragm, congenital malformation of diaphragm NOS, congenital eventration of the diaphragm, agenesis of diaphragm |
| C. Adult onset | Likelihood of first onset in adulthood very low — mostly diagnosed in the neonatal period or infancy. Mild eventration of the diaphragm is sometimes asymptomatic and found incidentally on chest X-ray in adulthood. |
| 1. History | History of classification of diaphragmatic malformations. Eventration first described by Petit in 1722. Diaphragmatic agenesis recognized as a variant of CDH. ICD-10 code Q79.1 groups other congenital diaphragmatic malformations apart from CDH. |
| 2. Causes | Impaired development of diaphragmatic muscle (eventration), complete agenesis of the diaphragm, congenital eventration of the diaphragm. Signaling abnormalities related to retinoic acid, GATA4 and WT1. Mostly sporadic. |
| 3. Genetics | Genetic background similar to CDH (GATA4, WT1, CHD7, etc.). Associated chromosomal abnormalities possible. Mostly sporadic. Familial diaphragmatic eventration is rare. |
| 4. General epidemiology | Diaphragmatic eventration: about 1/10,000~1/20,000 births. Complete agenesis is very rare. Code Q79.1 includes other congenital diaphragmatic malformations excluding CDH. |
| 5. Pathophysiology | Impaired development of the diaphragmatic muscle layer (eventration) → upward displacement of the diaphragm → lung compression → pulmonary hypoplasia (in severe eventration). With complete agenesis, the pathophysiology is the same as CDH. |
| 6. Symptoms | Mild: asymptomatic or recurrent respiratory infections. Severe: respiratory failure in the neonatal period (CDH-like). Eventration: dyspnea and cyanosis after feeding. Complete agenesis: severe respiratory failure. |
| 7. Signs | Chest X-ray: upward displacement of the affected hemidiaphragm, compressed lung shadow. Paradoxical upward movement of the affected hemidiaphragm on expiration. Paradoxical diaphragmatic motion on fluoroscopy. |
| 8. Screening | Fetal MRI added when a diaphragmatic abnormality is suspected on prenatal ultrasound (18~22 weeks of gestation). Chest X-ray and fluoroscopy in newborns with respiratory abnormalities after birth. |
| 9. Diagnosis | Chest X-ray (upward displacement of the diaphragm), fluoroscopy (confirmation of paradoxical motion), CT/MRI (evaluation of diaphragm shape and thickness), evaluation of associated anomalies. |
| 10. Treatment | Asymptomatic: observation. Symptomatic eventration: diaphragm plication. Complete agenesis: emergency surgery and intensive care as for CDH. |
| 11. Prognosis | Mild eventration: good. Complete agenesis: poor, as for CDH. Respiratory function recovers in most after plication. Presence of associated anomalies has a major impact on prognosis. |
| 12. Prevention | After prenatal diagnosis, plan delivery at a specialized tertiary medical institution. Genetic counseling (when there are associated genetic abnormalities). Avoid retinoid drugs during pregnancy. |
| 13. References | Simanovsky N et al. imaging of diaphragmatic eventration … and 9 other papers |
ICD-10 code Q79.1 is a classification covering other congenital malformations of the diaphragm excluding congenital diaphragmatic hernia (CDH, Q79.0), and includes agenesis of diaphragm, eventration of the diaphragm, and congenital malformation of diaphragm not elsewhere classified (NOS). Of these, the most frequently diagnosed clinically is congenital eventration of the diaphragm.
The historical record of congenital eventration of the diaphragm goes back to 1722, when the French surgeon Jean-Louis Petit first described an abnormally high diaphragm at autopsy. The term eventration derives from the Latin ex (out) + venter (belly) and refers to a condition in which the diaphragm is abnormally elevated. Congenital eventration results from impaired formation of the diaphragmatic muscle layer during fetal development and refers to a condition in which the diaphragm consists only of a thin fibrous membrane and is permanently elevated toward the thoracic cavity by abdominal pressure.
Historically, congenital eventration and CDH were often confused, but they are pathophysiologically distinct: in CDH there is an actual defect (hole) in the diaphragm through which organs herniate into the thoracic cavity, whereas in eventration the diaphragm itself is present but has lost muscle function, so the abdominal organs are displaced upward. This distinction also leads to differences in treatment strategy. As surgical treatment, Thomas first performed diaphragm plication in children in 1954 and reported successful results, and it subsequently developed into thoracotomy and laparoscopic and thoracoscopic approaches. In Korea as well, clinical experience with plication for diaphragmatic eventration has accumulated in pediatric surgery and thoracic surgery, and it is registered and managed under code Q79.1 as eligible for Special Copayment Reduction (V155).
Complete agenesis of the diaphragm is an ultra-rare malformation reported very rarely, a condition in which one or both hemidiaphragms are not formed at all. Clinically it resembles severe CDH, with severe respiratory failure and pulmonary hypoplasia in the neonatal period. This type has historically been regarded as an extreme form of CDH and is included in Q79.1 without an independent classification code.
The other congenital malformations of the diaphragm included in Q79.1 have somewhat different causes depending on their form, but all are attributable to abnormalities in fetal diaphragm development. The cause of congenital eventration of the diaphragm is failure of differentiation of the diaphragmatic muscle layer during fetal development. In normal diaphragm development, myoblasts originating from the cervical and thoracic somites must migrate into the septum between the thoracic and abdominal cavities (the membranous diaphragm) for muscularization to occur; if this migration or differentiation of myoblasts is abnormal, an eventrated diaphragm consisting only of a fibrous membrane without a muscle layer is formed. This fibrous membrane lacks sufficient mechanical strength to support the abdominal organs and becomes fixed in a position bulging toward the thoracic cavity.
Congenital eventration mostly occurs sporadically, and associated anomalies (cardiac malformations, central nervous system malformations, chromosomal abnormalities) are observed in about 10~20%. In some cases, differentiation from acquired eventration due to neonatal phrenic nerve injury is needed. Acquired eventration results from birth injury (cervical plexus injury in difficult delivery), and unlike the congenital form, the diaphragm muscle itself is normal but its innervation is lost.
Complete agenesis of the diaphragm is understood as an extreme form of CDH, and its causal mechanism is similar to CDH. It is thought to be a case in which abnormalities of the retinoic acid signaling pathway (related to transcription factors such as GATA4, WT1 and ZBTB16) completely block diaphragmatic muscle differentiation. Bilateral complete agenesis is known as a fatal malformation incompatible with survival, and some survival has been reported in unilateral complete agenesis with intensive care similar to CDH. As environmental factors, exposure to retinoid drugs during pregnancy and diabetic pregnancy have been reported to be associated with diaphragmatic malformations in some animal models, but a direct causal relationship in humans has not been established.
The genetics of the other congenital malformations of the diaphragm included in Q79.1 mainly share a genetic background with CDH (Q79.0). Familial occurrence of congenital diaphragmatic eventration is rare, and most cases are sporadic. However, diaphragmatic eventration may accompany some genetic syndromes (e.g., Beckwith-Wiedemann syndrome, Down syndrome, Edwards syndrome), so evaluation for associated genetic abnormalities is needed when eventration is diagnosed. In complete agenesis of the diaphragm, as in CDH, variants of diaphragm development-related genes such as GATA4, WT1 and CHD7, or chromosomal abnormalities, may be present.
In genotype-phenotype associations, even variants of the same gene (e.g., GATA4) may present as typical CDH (Q79.0) or as eventration (Q79.1), so genetic heterogeneity is great. This suggests that various diaphragmatic malformations can arise depending on the timing, location and degree of abnormalities occurring in the same developmental pathway. Diagnosis is possible from clinical and imaging findings alone even without molecular confirmation, and genetic testing is performed when associated genetic abnormalities are suspected or when prognostic assessment or family counseling is needed.
No large-scale genetic studies of the other congenital diaphragmatic malformations corresponding to Q79.1 have yet been reported in Korea. Given the nature of rare malformations, accumulation of cases and multicenter studies are needed, and with the spread of next-generation sequencing (NGS)-based gene panel testing, progress in identifying genetic causes is expected in the future. When familial or recurrent occurrence is suspected, referral to a medical geneticist and genetic counseling are recommended. Preimplantation genetic testing (PGT) can be considered only when a genetic cause has been identified.
Congenital eventration of the diaphragm is a rare congenital malformation occurring in about 1 in 10,000~20,000 births. A slightly higher incidence in boys has been reported, but the difference is not large. Eventration occurs more commonly on the left (about 60~70%) than on the right (about 30~40%), and bilateral eventration is very rare. The greater frequency of left-sided eventration is explained as related to anatomical characteristics that make myoblast migration in the left hemidiaphragm more vulnerable than on the right during development.
About 20% of all diaphragmatic eventrations are congenital (congenital eventration), and the remaining about 80% are acquired (acquired eventration) due to phrenic nerve injury (birth injury, complications after cardiac surgery). Therefore, the actual incidence of congenital eventration corresponding to Q79.1 is lower than the overall incidence of eventration. Complete agenesis of the diaphragm is an ultra-rare malformation with only a few dozen cases reported worldwide, and there are no accurate prevalence data. Bilateral complete agenesis is often found at autopsy of deceased fetuses, and unilateral complete agenesis also has high neonatal mortality.
Because code Q79.1 includes not only eventration and complete agenesis but also other congenital diaphragmatic malformations not elsewhere classified (NOS), the actual number of patients diagnosed under this code is slightly greater than the sum of eventration and complete agenesis. In Korea, Q79.1 is designated as eligible for rare disease Special Copayment Reduction (V155), and medical cost reduction benefits are provided once the diagnosis is confirmed. Accurate domestic incidence data could be obtained through analysis of Health Insurance Review & Assessment Service (HIRA) claims data or the congenital anomaly registry program, but official aggregate data to date are limited.
The pathogenesis of congenital eventration of the diaphragm is impaired formation of the diaphragmatic muscle layer during fetal development. The normal diaphragm begins to form around the 4th week of gestation, and muscularization is completed when myoblasts originating from the cervical 3~5 somites migrate into the fibrous primitive septum separating the abdominal and thoracic cavities. In congenital eventration, a defect in this migration or differentiation of myoblasts leaves part or all of the diaphragm without a muscle layer, with only a thin fibrous-serous membrane remaining. This membrane has no contractile function, cannot overcome intra-abdominal pressure, and becomes fixed in a position bulging toward the thoracic cavity.
The degree of upward displacement of the eventrated diaphragm depends on the extent of the defect, intra-abdominal pressure and the infant's respiratory effort. On inspiration, a normal diaphragm moves downward to increase thoracic volume, but an eventrated diaphragm shows paradoxical movement, moving upward instead on inspiration. This is due to the mechanics whereby, when negative intrathoracic pressure develops on inspiration, positive intra-abdominal pressure pushes the eventrated diaphragm further up. The more severe the paradoxical movement, the greater the ventilation-perfusion mismatch and the more severe the compression of the affected lung.
If compression of the affected lung due to eventration persists for a long time, reduced lung volume, airway collapse (atelectasis), recurrent lung infections and chronic respiratory failure develop. In severe neonatal eventration, pulmonary hypoplasia and persistent pulmonary hypertension of the newborn (PPHN) may accompany it, similar to CDH. In complete agenesis of the diaphragm, one or both hemidiaphragms are entirely absent, so abdominal organs are displaced into the thoracic cavity and pulmonary hypoplasia and PPHN develop by the same mechanism as CDH. In this case, emergency intensive care and surgical correction equivalent to CDH are needed.
Acquired eventration results from phrenic nerve injury; in this case the muscle layer of the diaphragm itself is normal, but innervation is lost and contractile ability is lost. It commonly occurs from birth injury (obstetric traction, especially shoulder dystocia) or as a complication after pediatric cardiac surgery, and although its clinical picture is similar to congenital eventration, it differs in etiology and in some aspects of prognosis. Acquired eventration may improve spontaneously if phrenic nerve function recovers, but plication is needed when the nerve injury is permanent.
The clinical symptoms of other congenital malformations of the diaphragm (Q79.1) vary greatly with the type of malformation (eventration vs. complete agenesis) and its severity. In mild congenital eventration, patients may be asymptomatic and then be found on chest X-ray in infancy or childhood prompted by recurrent pneumonia or respiratory infections. Conversely, in severe eventration or complete agenesis, severe respiratory failure similar to CDH develops in the neonatal period.
The representative symptoms of congenital eventration of the diaphragm are as follows. ①Respiratory failure: in mild cases, cyanosis or dyspnea appears intermittently during feeding or activity; in severe cases, there is persistent tachypnea, retractions and cyanosis. ②Recurrent respiratory infections: chronic compression of the affected lung impairs clearance of secretions, so pneumonia or bronchitis recurs. ③Feeding difficulty: when abdominal organs are displaced upward, gastroesophageal reflux (GERD) accompanies it, with vomiting after feeding and poor weight gain. ④Growth retardation: growth may be impaired due to chronic hypoxia and feeding problems. ⑤Reduced exercise tolerance: in childhood and adolescence, patients may complain that their exercise capacity is markedly lower than that of peers and that they easily become short of breath.
Complete agenesis of the diaphragm presents in the neonatal period in the same way as CDH. Immediately after birth, severe respiratory failure (tachypnea, retractions, cyanosis), a barrel-shaped chest, a scaphoid abdomen and absent breath sounds on the affected side on auscultation appear. In this case, immediate endotracheal intubation and neonatal intensive care are needed. In bilateral complete agenesis, most patients die of severe respiratory failure unresponsive to resuscitation. Mild eventration is sometimes found incidentally on a screening chest X-ray in adulthood, in which case patients may be asymptomatic or have nonspecific respiratory symptoms (mild exertional dyspnea, recurrent respiratory infections).
The physical signs of congenital eventration of the diaphragm are characterized by decreased breath sounds on the affected side of the chest, dullness or tympany on percussion over the affected hemidiaphragm (depending on bowel gas), and reduced chest expansion due to compression of the affected lung. In newborns or infants, respiratory worsening after feeding and cyanosis during feeding may be observed. On abdominal inspection, the upper abdomen on the affected side (especially in left-sided eventration) may be slightly depressed, or an abnormal stomach position may be palpable.
Radiological signs are central to diagnosis. On chest X-ray, the affected hemidiaphragm is markedly elevated (usually 2 or more intercostal spaces higher than the unaffected side), and the lower part of the affected lung is compressed. The gastric gas bubble is seen at an abnormally high position, or colonic shadows rise to the lower thoracic cavity. The difference from CDH is that in eventration the diaphragmatic line itself is visible (sometimes faintly or continuously), and the diaphragmatic line is not completely lost as in CDH.
Fluoroscopy is the most important functional test in the diagnosis of eventration. Eventration is diagnosed and its severity assessed by confirming in real time the paradoxical movement of the affected hemidiaphragm during respiration (upward on inspiration, downward on expiration). A 'seesaw movement', in which the affected side moves upward while the unaffected hemidiaphragm moves normally downward, is characteristic. CT or MRI is used to precisely evaluate the thickness and continuity of the diaphragm and its anatomical relationship to surrounding organs, and is important for preoperative planning. Ultrasound is useful for noninvasive real-time bedside evaluation of diaphragmatic movement and is particularly widely used in neonatal intensive care units.
There is no specific newborn screening test for other congenital malformations of the diaphragm (Q79.1). If findings suggestive of a diaphragmatic abnormality (abnormally high position of the affected hemidiaphragm, displacement of abdominal organs into the thoracic cavity, etc.) are observed on prenatal ultrasound (detailed ultrasound at 18~22 weeks of gestation), further detailed evaluation is performed. Because in congenital eventration, unlike CDH, organs are displaced (elevation) rather than completely herniated into the thoracic cavity, the diagnosis is missed on prenatal ultrasound more often than CDH.
If eventration is suspected on prenatal ultrasound, fetal MRI is performed to precisely evaluate the position and thickness of the diaphragm, the presence of herniated organs, lung volume, etc. If associated anomalies are suspected, chromosomal karyotyping, CMA and, if needed, WES are performed to evaluate for genetic abnormalities. After birth, a chest X-ray is performed immediately in newborns with respiratory abnormalities, and if eventration is suspected, diaphragmatic movement is evaluated by fluoroscopy or bedside ultrasound.
Clinical situations in which eventration should be suspected are as follows: ① recurrent pneumonia or respiratory failure in newborns and infants, ② abnormally high position of the affected hemidiaphragm on chest X-ray, ③ dyspnea that worsens after feeding, ④ decreased breath sounds over the affected lung. If these findings are present, the patient is immediately referred to a pediatric surgeon or pediatric pulmonologist for detailed evaluation. To differentiate acquired eventration (birth injury, after cardiac surgery), the birth history and surgical history must also be checked.
The diagnosis of other congenital malformations of the diaphragm is made by clinical findings, radiological findings and functional tests. If the characteristic findings of eventration (upward displacement of the affected hemidiaphragm, compression of the lower affected lung) are confirmed on chest X-ray, a clinically suspected diagnosis is possible. For confirmation, paradoxical diaphragmatic movement (upward movement on inspiration) is confirmed by fluoroscopy or real-time ultrasound.
CT is very useful for the anatomical evaluation of eventration. It can accurately evaluate the degree of upward displacement of the affected hemidiaphragm, the thickness and continuity of the diaphragm, the presence of herniated organs, the degree of reduction in affected lung volume and the presence of associated anomalies. In typical eventration, the continuity of the diaphragm is maintained (seen as a thin membrane), and unlike CDH there is no actual defect. Contrast-enhanced CT or CT angiography can be used to evaluate vascular anomalies or circulatory disturbances accompanying eventration. MRI is useful for evaluating anatomical details without radiation exposure and may be preferred especially in infants and newborns.
Clinical differentiation from CDH (Q79.0) is most important. In CDH there is an actual defect in the diaphragm, so on chest X-ray the diaphragmatic line is completely lost and bowel shadows are observed independently within the thoracic cavity, whereas in eventration the diaphragmatic line is preserved, though faint, and the bowel shadows appear to have risen above the diaphragm. On fluoroscopy, paradoxical movement is prominently observed in eventration. To differentiate acquired eventration, delivery records, presence of obstetric injury and records of previous thoracic or cardiac surgery are checked. Congenital eventration is present from birth and thereafter does not improve or progresses, whereas acquired eventration (birth injury) is normal immediately after birth, appears gradually after the injury, and in some cases recovers spontaneously.
The treatment of congenital eventration of the diaphragm is determined by the presence of symptoms and severity. In asymptomatic or mildly symptomatic eventration, observation is possible, with management by regular follow-up chest X-rays and clinical evaluation. Symptoms sometimes improve naturally with growth, but the eventration itself does not resolve spontaneously. In symptomatic eventration with recurrent pneumonia, persistent respiratory failure, growth retardation, reduced exercise tolerance, etc., surgical treatment is performed.
Diaphragm plication is the standard surgical treatment for congenital eventration. It is a method in which the eventrated diaphragm is folded in multiple layers radially or concentrically and sutured to increase tension and correct the upward displacement. Thoracotomy, thoracoscopic surgery (VATS, video-assisted thoracoscopic surgery), or laparoscopic or robot-assisted approaches are chosen according to patient age, size and the extent of eventration. The thoracoscopic approach has recently been applied safely in children as well and has the advantages of less postoperative pain and faster recovery than thoracotomy. After plication, the volume of the affected lung increases and paradoxical movement is corrected, markedly improving respiratory function. Surgical outcomes are generally good, and in most patients weaning from mechanical ventilation and establishment of spontaneous breathing are possible within several weeks after surgery.
Severe neonatal eventration or complete agenesis of the diaphragm requires emergency intensive care equivalent to CDH. Immediately after birth, endotracheal intubation, mechanical ventilation (lung-protective strategy), iNO and, if needed, ECMO are provided, and surgical correction is performed after hemodynamic stabilization. Complete agenesis requires diaphragmatic reconstruction using a prosthetic patch. For associated PPHN, pulmonary vasodilators such as sildenafil and milrinone are used. After surgery, multidisciplinary management of gastroesophageal reflux, nutritional support and respiratory rehabilitation is needed.
The prognosis of congenital eventration of the diaphragm varies with the extent of eventration (partial vs. complete), timing of presentation (neonatal vs. infancy or childhood) and presence of associated anomalies. In patients with mild eventration who are asymptomatic or mildly symptomatic, most achieve normal growth and development with conservative management or after plication, and the prognosis is good. In severe eventration presenting in the neonatal period or complete agenesis, mortality is high, as in CDH, and long-term complications occur in survivors.
The short-term prognosis after plication is generally good. After surgery, the volume of the affected lung increases and respiratory function improves, shortening the duration of weaning from mechanical ventilation. In long-term follow-up, respiratory function recovers to a normal or mildly reduced level after surgery in most patients. However, recurrence of eventration after plication (loosening of sutures or re-stretching of the plicated area) is reported in about 5~15%, so long-term follow-up is needed. Reoperation may be needed upon recurrence. The long-term prognosis of isolated eventration without associated anomalies is generally very good, and most patients can lead normal academic, physical and social lives.
The prognosis of complete agenesis of the diaphragm is severe, similar to CDH (Q79.0), and liver herniation, severe PPHN and bilateral occurrence in particular are poor prognostic factors. The prognosis is also poor when there are associated genetic abnormalities. In survivors, long-term complications similar to CDH, such as reduced lung function, gastroesophageal reflux and neurodevelopmental abnormalities, may occur. Long-term multidisciplinary follow-up (pediatric surgery, pediatric pulmonology, pediatric gastroenterology, pediatric development, nutrition) is recommended.
There is no established method of directly preventing the occurrence of other congenital malformations of the diaphragm (Q79.1). When prenatal diagnosis has been made, planning delivery at a specialized tertiary medical institution so that optimal management can begin immediately after birth is the most important strategy for improving survival. If eventration or a diaphragmatic abnormality is suspected on prenatal ultrasound, the patient should immediately be referred to a tertiary medical institution with a maternal-fetal medicine (MFM) team or a pediatric surgery team for detailed evaluation and delivery planning.
Because use of retinoid drugs (isotretinoin, etc.) during pregnancy is associated with the development of diaphragmatic malformations, including CDH, they should not be used during pregnancy without a physician's prescription. Folic acid supplementation (from 3 months before pregnancy to 3 months of pregnancy) is known to be effective in preventing several congenital malformations such as neural tube defects, but specific evidence for the prevention of diaphragmatic malformations is still lacking. Following general rules for a healthy pregnancy, avoiding smoking, alcohol and unnecessary medications during pregnancy, is recommended.
When associated genetic abnormalities have been identified (especially when familial occurrence due to a single-gene variant is suspected), recurrence risk and prevention strategies are discussed through genetic counseling. Preimplantation genetic testing (PGT) can be considered only when the causative genetic variant has been identified. After the birth of a child with eventration, detailed prenatal ultrasound is performed intensively in the next pregnancy to monitor for recurrence. In patients after plication for eventration, recurrence is monitored by regular follow-up chest X-rays and clinical evaluation, and whether to reoperate is decided upon recurrence.
Simanovsky N, Kogut V, Hiller N. The imaging of congenital diaphragmatic eventration. Clin Imaging. 2008;32(2):164-166. DOI: 10.1016/j.clinimag.2007.04.021. PMID: 18313567.
Thomas TV. Congenital eventration of the diaphragm. Ann Thorac Surg. 1970;10(2):180-192. DOI: 10.1016/s0003-4975(10)65574-3. PMID: 5448558.
Shono T, Suita S, Arima T, Hirose R. Congenital diaphragmatic eventration in children — a rare cause of respiratory distress. Eur J Pediatr Surg. 1994;4(6):356-359. DOI: 10.1055/s-2008-1066133. PMID: 7894764.
Chin EF, Lynn RB. Surgery of eventration of the diaphragm. J Thorac Surg. 1956;32(1):6-14. PMID: 13331413.
Scaife ER, Johnson DG, Meyers RL, Johnson SM, Matlak ME. The split abdominal wall muscle flap — a simple, mesh-free approach to repair large diaphragmatic hernia. J Pediatr Surg. 2003;38(12):1748-1751. DOI: 10.1016/j.jpedsurg.2003.08.020. PMID: 14666451.
Smith BM, Sade RM, Crawford FA Jr, Othersen HB Jr. Diaphragmatic paralysis and eventration in infants. J Thorac Cardiovasc Surg. 1986;91(4):490-497. PMID: 3951139.
Joho-Arreola AL, Bauersfeld U, Stauffer UG, Baenziger O, Bernet V. Incidence and treatment of diaphragmatic paralysis after cardiac surgery in children. Eur J Cardiothorac Surg. 2005;27(1):53-57. DOI: 10.1016/j.ejcts.2004.09.024. PMID: 15621469.
Mouroux J, Venissac N, Leo F, Alifano M, Guillot F. Surgical treatment of diaphragmatic eventration using video-assisted thoracoscopy: a prospective study. Ann Thorac Surg. 2005;79(1):308-312. DOI: 10.1016/j.athoracsur.2004.07.023. PMID: 15620963.
Wynn J, Yu L, Chung WK. Genetic causes of congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 2014;19(6):324-330. DOI: 10.1016/j.siny.2014.09.003. PMID: 25263546.
Deprest JA, Nicolaides KH, Benachi A, et al. Randomized trial of fetal surgery for severe left diaphragmatic hernia (TOTAL). N Engl J Med. 2021;385(2):107-118. DOI: 10.1056/NEJMoa2027030. PMID: 34260844.